Researchers Discover Immune-Based Biomarker That May Aid in Early Detection of Ovarian Cancer
Researchers from the Children’s Hospital of Philadelphia (CHOP) have uncovered a biomarker that can be detected in the blood up to four years before high-grade ovarian cancer (HGOC) is typically diagnosed. This discovery can potentially be a “game-changer” in early detection of ovarian cancer and could advance pediatric cancer research as well. Overview of Ovarian … Read more